covovax-
DCGI approves market authorisation for SII’s Covid vaccine Covovax as heterologous booster dose-
By PTI NEW DELHI: The Drug Controller General of India (DCGI) has approved market authorisation to COVID-19 vaccine Covovax as ...
Commercial use of SII’s Covovax as heterologous booster jab gets government nod-
By Express News Service NEW DELHI: An expert panel of the central drug regulatory authority has recommended market authorisation for ...
Govt panel recommends market authorisation for Covovax jab as heterologous booster dose-
By PTI NEW DELHI: An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute ...
Covovax to get approval as booster in 10-15 days, says SII CEO Adar Poonawalla-
By PTI PUNE: Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get ...
SII seeks nod to export 32.4 lakh doses of its Covid vaccine Covovax to US-
By PTI NEW DELHI: The Serum Institute has sought the Centre’s approval to export 32.4 lakh doses of the COVID-19 ...
Government panel recommends emergency approval for SII’s Covovax for 7-11 year olds-
By PTI NEW DELHI: An expert panel of India’s central drug authority on Friday recommended granting emergency use authorisation to ...
DCGI to review Serum Institute’s applications for Covovax use in kids aged 2 to 7 yrs, 7 to 11 yrs-
By PTI NEW DELHI: The subject expert committee on COVID-19 of India’s drug regulator will on Friday review the applications ...
SII lowers each dose of Covovax jab from Rs 900 to Rs 225 excluding taxes-
By PTI NEW DELHI: A day after its Covid shot Covovax was included on the CoWIN portal for inoculation of ...
SII’s COVID vaccine Covovax now available for 12-17 age group at private centres-
By PTI NEW DELHI: Children aged 12 to 17 years can now get the Serum Institute’s coronavirus vaccine Covovax at ...
Advisory Group recommends Covovax for 12-17 children; no decision yet on vaccinating kids below 12 –
Express News Service NEW DELHI: The National Technical Advisory Group on Immunization (NTAGI) has approved the Serum Institute’s Covid-19 Covovax ...
